磺胺二甲唑结构式
|
常用名 | 磺胺二甲唑 | 英文名 | sulfamoxol |
|---|---|---|---|---|
| CAS号 | 729-99-7 | 分子量 | 267.30400 | |
| 密度 | 1.411g/cm3 | 沸点 | 481ºC at 760 mmHg | |
| 分子式 | C11H13N3O3S | 熔点 | 197-199℃ | |
| MSDS | 中文版 美版 | 闪点 | 244.7ºC | |
| 符号 |
GHS07 |
信号词 | Warning |
磺胺二甲唑用途Sulfamoxole 是一种广谱化疗抗菌(antimicrobial agent) 试剂。Sulfamoxole 可用于小儿感染的相关研究。 |
| 中文名 | 磺胺二甲唑 |
|---|---|
| 英文名 | sulfamoxole |
| 中文别名 | 磺胺二甲恶唑 | 磺胺噁唑 |
| 英文别名 | 更多 |
| 描述 | Sulfamoxole 是一种广谱化疗抗菌(antimicrobial agent) 试剂。Sulfamoxole 可用于小儿感染的相关研究。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.411g/cm3 |
|---|---|
| 沸点 | 481ºC at 760 mmHg |
| 熔点 | 197-199℃ |
| 分子式 | C11H13N3O3S |
| 分子量 | 267.30400 |
| 闪点 | 244.7ºC |
| 精确质量 | 267.06800 |
| PSA | 106.60000 |
| LogP | 3.40940 |
| InChIKey | CYFLXLSBHQBMFT-UHFFFAOYSA-N |
| SMILES | Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C |
| 折射率 | 1.626 |
| 储存条件 | 库房通风低温干燥 |
| 计算化学 | 1.疏水参数计算参考值(XlogP):1.3 2.氢键供体数量:2 3.氢键受体数量:6 4.可旋转化学键数量:3 5.互变异构体数量:2 6.拓扑分子极性表面积:107 7.重原子数量:18 8.表面电荷:0 9.复杂度:374 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
|
~%
磺胺二甲唑 729-99-7 |
| 文献:DE1003737 , ; |
|
~%
磺胺二甲唑 729-99-7 |
| 文献:DE1003737 , ; US2809966 , ; |
|
~%
磺胺二甲唑 729-99-7 |
| 文献:DE1003737 , ; US2809966 , ; |
|
~%
磺胺二甲唑 729-99-7 |
| 文献:DE1003737 , ; US2809966 , ; |
|
~%
磺胺二甲唑 729-99-7 |
| 文献:DE1003737 , ; |
|
Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis.
Adverse Drug React. Toxicol. Rev. 15(1) , 9-50, (1996)
|
|
|
Combination of trimethoprim with sulfonamides other than sulfamethoxazole.
Rev. Infect. Dis. 4(2) , 411-8, (1982) Early in the development of trimethoprim (TMP), the response to the drug was less than enthusiastic. Preliminary clinical trials were performed with sulfonamides that were unsuitable partners. On the ... |
|
|
Use of p-benzoquinone for the spectrophotometric determination of certain sulphonamides.
J. Pharm. Biomed. Anal. 9(7) , 531-8, (1991) A simple spectrophotometric method for the determination of 15 sulphonamides in bulk and in dosage forms is described. The method is based on the interaction of p-benzoquinone with sulphonamides in 0.... |
| SULFAMOXOLE |
| Sulfamoxol |
| 4-amino-N-(4,5-dimethyl-1,3-oxazol-2-yl)benzenesulfonamide |
| Sulphamoxole |
| Sulfavigor |
| sulphamoxazole |
| Oxasulfa |
| Sulfmidil |
| Sulfadimethyloxazole |
| Sulfamoxolum |
| Justamil |
| sulfisoxazole |
| Sulfuno |